A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.
第一作者:
Andrew D,Krystal
第一单位:
Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA. andrew.krystal@ucsf.edu.;Departments of Psychiatry and Behavioral Sciences and Radiology, Duke University School of Medicine, Durham, NC, USA. andrew.krystal@ucsf.edu.
作者:
医学主题词
成年人(Adult);焦虑症(Anxiety Disorders);苯甲酰胺类(Benzamides);中枢神经系统药物(Central Nervous System Agents);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);情绪障碍(Mood Disorders);麻醉品拮抗药(Narcotic Antagonists);吡咯烷类(Pyrrolidines);受体, 阿片样, κ(Receptors, Opioid, kappa);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1038/s41591-020-0806-7
PMID
32231295
发布时间
2023-02-24
- 浏览13
Nature medicine
760-768页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



